Yolo Group Valuation
Is X2Y undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of X2Y when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate X2Y's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate X2Y's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for X2Y?
Key metric: As X2Y is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is X2Y's PS Ratio? | |
|---|---|
| PS Ratio | 1.5x |
| Sales | €9.70m |
| Market Cap | €14.55m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1.1x |
| Enterprise Value/EBITDA | -7.5x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does X2Y's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 2.2x | ||
DFV DFV Deutsche Familienversicherung | 0.7x | n/a | €95.5m |
RLV RheinLand Holding | 0.2x | n/a | €119.0m |
TBK Transilvania Broker de Asigurare | 0.7x | n/a | RON 79.8m |
ENA Ensurance | 7x | n/a | AU$24.3m |
X2Y Yolo Group | 1.5x | 50.4% | €14.5m |
Price-To-Sales vs Peers: X2Y is expensive based on its Price-To-Sales Ratio (1.5x) compared to the peer average (0.6x).
Price to Sales Ratio vs Industry
How does X2Y's PS Ratio compare vs other companies in the European Insurance Industry?
| 2 Companies | Price / Sales | Estimated Growth | Market Cap |
|---|---|---|---|
| 2 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Sales vs Industry: X2Y is expensive based on its Price-To-Sales Ratio (1.5x) compared to the European Insurance industry average (1x).
Price to Sales Ratio vs Fair Ratio
What is X2Y's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 1.5x |
| Fair PS Ratio | 0.2x |
Price-To-Sales vs Fair Ratio: X2Y is expensive based on its Price-To-Sales Ratio (1.5x) compared to the estimated Fair Price-To-Sales Ratio (0.2x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
China Life Insurance
HK$1.1t
Operates as a life insurance company in the People’s Republic of China.
CHL
HK$1.90
7D
-3.6%
1Y
46.8%
AXA
€72.3b
Through its subsidiaries, provides insurance, asset management, and banking services worldwide.
AXA
€34.20
7D
-0.6%
1Y
20.7%
Beazley
UK£4.6b
Provides risk insurance and reinsurance solutions in the United States, the United Kingdom, rest of Europe, and internationally.
2D7
UK£8.65
7D
-8.9%
1Y
38.5%